+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty



Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty



Journal of the American College of Cardiology 43(8): 1363-1367



OBJECTIVES The aim of the study was to evaluate the impact of preprocedural Thrombolysis In Myocardial Infarction (TIMI) flow on one-year mortality in patients with ST-segment elevation myocardial infarction (STEMI) treated by primary angioplasty. BACKGROUND Although there is an excellent outcome conferred by primary angioplasty in patients with STEMI, the prognostic role of early recanalization in these patients has yet to be investigated. METHODS Our population is composed of 1,791 patients with acute myocardial infarction treated by primary angioplasty at our institution from 1994 to 2001. All angiographic, clinical, and follow-up data were prospectively collected. According to the TIMI risk score, patients were stratified in low- and high-risk groups. RESULTS Preprocedural TIMI flow was related to postprocedural TIMI flow grade 3 (p = 0.002), myocardial blush grade 2 to 3 (p < 0.001), enzymatic infarct size (p < 0.001), predischarge ejection fraction (p < 0.001), and one-year mortality (p < 0.05). Multivariate analysis showed that preprocedural TIMI flow grade 3 was an independent predictor of one-year survival in high-risk patients (p < 0.05). CONCLUSIONS This study shows that preprocedural TIMI flow grade 3 is an independent predictor of one-year survival in high-risk patients with acute myocardial infarction treated by primary angioplasty. These data suggest that all efforts should be made to obtain early and optimal restoration of antegrade flow, particularly in high-risk patients and when transportation to tertiary centers, with a conceivable further time delay, is required. Copyright 2004 by the American College of Cardiology Foundation.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012444359

Download citation: RISBibTeXText

PMID: 15093868

DOI: 10.1016/j.jacc.2003.11.042


Related references

Preprocedural Thrombolysis in Myocardial Infarction (TIMI) flow significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute anterior myocardial infarction treated by primary angioplasty. American Heart Journal 150(4): 827-831, 2005

Impact of preprocedural TIMI flow on myocardial perfusion, distal embolization and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb/IIIa inhibitors. Journal of Invasive Cardiology 24(7): 324-327, 2013

Abortion of myocardial infarction by primary angioplasty mainly depends on preprocedural TIMI flow. Eurointervention 6(7): 854-859, 2011

Usefulness of the presence of peripheral vascular disease in predicting mortality in acute myocardial infarction patients treated with primary angioplasty (from the Primary Angioplasty in Myocardial Infarction Database). American Journal of Cardiology 96(5): 649-654, 2005

Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis Results from the pooled data of the Maximal Individual Therapy in acute myocardial infarction registry and the Myocardial Infarction Registry. Journal of the American College of Cardiology 36(7): 2064-2071, December, 2000

Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis: Results from the pooled data of the Maximal Individual Therapy in acute myocardial infarction (MITRA) registry and the Myocardial Infarction Registry (MIR). Journal of the American College of Cardiology 36(7): 2064-2071, 2000

Predictors of TIMI ltoreq 2 coronary flow after primary angioplasty in patients with acute myocardial infarction. Journal of the American College of Cardiology 35(2 suppl A): 20A, 2000

TIMI 3 flow after primary angioplasty is an important predictor for outcome in patients with acute myocardial infarction. Clinical Research in Cardiology 98(3): 165-170, 2008

Relation of mortality of primary angioplasty during acute myocardial infarction to door-to-thrombolysis in myocardial infarction (TIMI) time. American Journal of Cardiology 91(12): 1401-1405, 2003

Comparison of the improvement in myocardial perfusion and function in cases of rapid and slow electrocardiographic stage dynamics between patients with TIMI-3 flow after primary angioplasty for acute myocardial infarction. Medicina 51(4): 217-221, 2016

Short-term clinical and TIMI 3 flow rate after combined thrombolysis versus primary angioplasty in acute myocardial infarction The Asia-Pacific acute myocardial infarction trial pilot study. American Journal of Cardiology 86(Suppl 8A): 7i, October 16, 2000

Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: Analysis from the primary angioplasty in myocardial infarction trials. Circulation 104(6): 636-641, 2001